City

Clinical trials near Vienna, Austria

Active studies with a listed research site in Vienna, Austria.

17active studies

12recruiting now

21countries represented

563largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowPhase 3

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Metabolic Dysfunction-Associated Steatotic Liver DiseaseCondition

Tirzepatide, RetatrutideTreatment

Argentina, Australia563 locations

Eli Lilly and CompanySponsor

Updated 2026-09-08 · NCT07165028See eligibility →

Recruiting nowPhase 3

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Ulcerative Colitis, Obesity or OverweightCondition

Mirikizumab, MirikizumabTreatment

Austria, Belgium187 locations

Eli Lilly and CompanySponsor

Updated 2026-09-04 · NCT06937086See eligibility →

Recruiting nowPhase 3

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Crohn's Disease, Obesity or OverweightCondition

Mirikizumab, MirikizumabTreatment

Austria, Belgium183 locations

Eli Lilly and CompanySponsor

Updated 2026-09-04 · NCT06937099See eligibility →

Recruiting nowPhase 3

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

Metabolic Dysfunction Associated SteatohepatitisCondition

Survodutide, Placebo matching survodutideTreatment

Argentina, Australia445 locations

Boehringer IngelheimSponsor

Updated 2026-09-03 · NCT06632457See eligibility →

Recruiting nowPhase 3

A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

Obesity, Type 2 DiabetesCondition

Cagrisema, SemaglutideTreatment

Argentina, Australia303 locations

Novo Nordisk A/SSponsor

Updated 2026-08-31 · NCT07564414See eligibility →

Recruiting nowPhase 3

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

Metabolic Dysfunction Associated Steatohepatitis (MASH), Liver FibrosisCondition

Survodutide, PlaceboTreatment

Argentina, Australia528 locations

Boehringer IngelheimSponsor

Updated 2026-08-21 · NCT06632444See eligibility →

Recruiting nowNot applicable

Metabolic Control of Aging and Disease - the MetAGE Deep Phenotyping Cohort

Obesity, AgingCondition

comprehensive metabolic phenotypingTreatment

Austria2 locations

Thomas SchererSponsor

Updated 2026-02-17 · NCT06511297See eligibility →

Recruiting nowNot applicable

Night Shift Work and Biomarkers of Obesity Risk in Hospital and Industry Workers

Obesity, Shift-work DisorderCondition

No interventionTreatment

Austria1 locations

University of ViennaSponsor

Updated 2025-09-08 · NCT06288568See eligibility →

Recruiting nowNot applicable

Hop Compounds on the Immune System in Overweight People

Inflammatory ResponseCondition

Xanthohumol, Iso-alpha AcidsTreatment

Austria1 locations

University of ViennaSponsor

Updated 2025-04-15 · NCT06745102See eligibility →

Recruiting nowNot applicable

Cohort Study on Plant-based Diets (COPLANT Study)

Dietary Exposure, Diabetes Mellitus, Type 2Condition

Intervention not listedTreatment

Austria, Germany8 locations

German Federal Institute for Risk AssessmentSponsor

Updated 2025-02-14 · NCT06323538See eligibility →

Recruiting nowNot applicable

AI-POD Clinical Validation Study for Obese Patients

Acute Cardiovascular DiseaseCondition

Non InterventionalTreatment

Austria, Belgium6 locations

University Hospital, BonnSponsor

Updated 2024-09-19 · NCT06595134See eligibility →

Recruiting nowPhase 4

Effects of Testosterone Undecanoate vs Placebo on Intrahepatic Fat Content in Overweight/Obese Men With T2DM or Prediabetes and Hypogonadism

Fatty Liver, Overweight/ObesityCondition

Testosterone Undecanoate, PlaceboTreatment

Austria1 locations

Alexandra Kautzky-WillerSponsor

Updated 2024-03-13 · NCT03851627See eligibility →

Opening soonNot applicable

Personalized Pharmaco-Lifestyle Interventions for Severe Mental Illnesses (LIFETRAIN)

Severe Mental Illness, Depression / Major Depressive DisorderCondition

Semaglutide (SEMA), Exercise moduleTreatment

Austria, Germany5 locations

Ludwig-Maximilians - University of MunichSponsor

Updated 2026-05-14 · NCT07586150See eligibility →

Active, not recruitingPhase 3

Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)

Non-alcoholic SteatohepatitisCondition

Semaglutide, PlaceboTreatment

Argentina, Australia558 locations

Novo Nordisk A/SSponsor

Updated 2026-09-04 · NCT04822181See eligibility →

Active, not recruitingPhase 1, Phase 2

A Trial to Learn How Safe AZD9550 Monotherapy and Combined With AZD6234 is in People With or Without Type 2 Diabetes Who Are Living With Obesity and Overweight

Overweight and ObesityCondition

AZD9550, placeboTreatment

Austria, Canada15 locations

AstraZenecaSponsor

Updated 2026-08-26 · NCT06151964See eligibility →

Active, not recruitingPhase 2

A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes

Overweight, ObesityCondition

Tirzepatide, PlaceboTreatment

Austria, Canada27 locations

Eli Lilly and CompanySponsor

Updated 2026-05-08 · NCT05536804See eligibility →

Active, not recruitingNot applicable

Multinational Point Prevalence Study on the Management of Diabesity in Hospitals

Diabetes Mellitus, ObesityCondition

Routine care for people with diabetes, with or without obesity, in the hospital settingTreatment

Austria, Czechia8 locations

Medical University of ViennaSponsor

Updated 2025-05-08 · NCT06680674See eligibility →

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.

Clinical trials near Vienna, Austria

Current studies

Related cities